Automated Author Profile

Wingfield, Paul

National Institutes of Health

Current S-Index

1.5

Sum of Dataset Indices for all datasets

Average Dataset Index per Dataset

1.5

Average Dataset Index per dataset

Total Datasets

1

Total datasets for this author

Average FAIR Score

69.2%

Average FAIR Score per dataset

Total Citations

0

Total citations to the author's datasets

Total Mentions

0

Total mentions of the author's datasets

S-Index Interpretation

S-Index Over Time

Cumulative Citations Over Time

Cumulative Mentions Over Time

Datasets

The ribosome-inactivating proteins MAP30 and Momordin inhibit SARS-CoV-2 (Version: 4)

These data are related to a manuscript submitted to PLOS ONE. The recombinant proteins MAP30 and Momordin, prepared at the National Institute of Arthritis and Musculoskeletal and Skin Diseases, were analyzed for SARS-CoV-2 inhibition using A549-NLRV human lung cell assays performed at Southern Research during the Covid-19 pandemic. All viral inhibition and cell viability values reported can be derived from the raw data provided here. Some data are replicates. File dates correspond to those originally provided by and preserved at Southern Research, Birmingham AL.

Authors

  • Watts, Norman ;
  • Eren, Elif ;
  • Palmer, Ira ;
  • Huang, Paul ;
  • Huang, Philip ;
  • Shoemaker, Robert ;
  • Lee-Huang, Sylvia ;
  • Wingfield, Paul
0 Citations0 Mentions69% FAIR1.5 Dataset Index
10.5061/dryad.z08kprrj4May 2023